(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays) By ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

According to a filing with the U.S. Securities and Exchange Commission dated November 14, Commodore Capital LP disclosed a new stake in Amylyx Pharmaceuticals (NASDAQ:AMLX). The fund reported ...

Cancer’s deadliest talent is not rapid growth but the ability to sidestep the internal programs that should make damaged ...

Mitochondria, the “powerhouses of the cell,” are vital cellular organelles that govern energy metabolism, maintain redox homeostasis, synthesize biomacromolecules, and initiate and transmit cell death ...

Findings expand Telomir-1's oncology profile into cancers of the blood, adding to previously reported activity in ...

Recent scientific breakthroughs suggest that manipulating a hidden “death switch” in our cells could significantly slow the ...

Restoring P53's autonomous anti-cancer function through P53 mRNA delivery is a promising anti-tumor strategy. Yet, in tumors harboring mutant P53, the existing mutant P53 (Mutp53) would interferes ...

The authors identify the Bearded-type small protein E(spl)m4 as a physical and genetic interactor of TRAF4 in the Drosophila wing disc. These valuable findings with potential biomedical relevance are, ...

Insilico Medicine ("Insilico"), a global leader in AI-powered drug discovery, and Atossa Therapeutics ("Atossa") (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel treatments ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...